<DOC>
	<DOCNO>NCT01124214</DOCNO>
	<brief_summary>Endomicroscopy ( EM ) improve diagnosis Barrett 's esophagus ( BE ) early esophageal cancer ( Intra Epithelial Neoplasia ( IEN ) ) . EM provide optical biopsy comparable standard histology . Specifically , EM allow target biopsy rather random mucosal biopsy routine endoscopic surveillance BE evaluation EIN , improve diagnostic yield mucosal sample BE IEN . Furthermore , combine high resolution endoscopy , EM may improve overall vivo detection IEN lesion well flat mucosa . EM provide accurate place size IEN impact physician 's decision biopsy perform endoscopic mucosal resection ( EMR ) . This could potentially minimize number unnecessary biopsy well enable physician perform EMR time initial examination , rather delay endoscopic treatment pathology available . This study important validate single center study support routine use EM screening surveillance BE .</brief_summary>
	<brief_title>Confocal Endomicroscopy Improved Diagnosis Barrett 's Esophagus Early Esophageal Cancer ( CEBE Study )</brief_title>
	<detailed_description>The central hypothesis endomicroscopy ( EM ) improve efficiency endoscopic diagnosis Barrett 's esophagus ( BE ) associate Intraepithelial neoplasia ( IEN ) , provide in-vivo optical biopsy comparable standard histology . Specifically , EM enable target biopsy rather random mucosal biopsy routine endoscopic surveillance BE endoscopic evaluation patient suspect proven unlocalized IEN , improve diagnostic yield mucosal sample BE IEN . Furthermore , combine high resolution endoscopy , EM may improve overall vivo detection IEN lesion well flat mucosa . The investigator also hypothesize EM provide additional accurate information regard presence IEN impact upon physician 's decision obtain mucosal biopsy perform endoscopic mucosal resection ( EMR ) . This could potentially minimize number unnecessary biopsy well enable physician perform EMR time initial examination , rather delay endoscopic treatment another procedure pathology mucosal biopsy available . This study important validate single center study support routine use EM screening surveillance BE .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<criteria>Surveillance Barrett 's esophagus suspect know BE associate neoplasia Allergy prior reaction fluorescent contrast agent fluorescein sodium Unable give inform consent . Pregnant breastfeeding woman Known advance adenocarcinoma esophagus Dysplastic suspect malignant esophageal lesion 0 BE lesion 2 cm size Paris classification 0Ip ( polypoid ) , 0Is ( protrude sessile ) , 0IIa ( flat elevate ) , 0IIb ( flat ) Lesions size Paris 0IIc ( superficial shallow depress ) 0III ( excavate ) Acute gastrointestinal bleeding Coagulopathy define Partial Thromboplastin Time ( PTT ) &gt; 50 sec , International Normalized Ratio ( INR ) &gt; 2.0 , platelet &lt; 40,000 , chronic anticoagulation Inability tolerate sedate upper endoscopy due cardiopulmonary instability contraindication endoscopy . History severe allergic reaction ( anaphylaxis ) Known , untreated esophageal stricture , prior partial esophageal resection , alter anatomy preventing passage endomicroscope</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Barrett 's</keyword>
	<keyword>BE</keyword>
	<keyword>esophageal cancer</keyword>
	<keyword>esophageal dysplasia</keyword>
</DOC>